Roundview Capital LLC Eli Lilly & CO Transaction History

Roundview Capital LLC

$1.35 Billion
Q3 2024

A detailed history of Roundview Capital LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Roundview Capital LLC holds 3,445 shares of LLY stock, worth $2.51 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

3,445

Previous 3,354 2.71%

Holding current value

$2.51 Million

Previous $3.04 Million 0.53%

% of portfolio

0.23%

Previous 0.24%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $70,264 - $87,361	91 Added 2.71%	3,445 $3.05 Million
Q2 2024 Aug 09, 2024	BUY	$724.87 - $909.04 $133,376 - $167,263	184 Added 5.8%	3,354 $3.04 Million
Q1 2024 May 06, 2024	BUY	$592.2 - $792.28 $199,571 - $266,998	337 Added 11.9%	3,170 $2.47 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $265,220 - $312,660	505 Added 21.69%	2,833 $1.65 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $17,822 - $24,571	41 Added 1.79%	2,328 $1.25 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $28,059 - $37,518	-80 Reduced 3.38%	2,287 $1.07 Million
Q1 2023 May 09, 2023	SELL	$310.63 - $364.82 $123,320 - $144,833	-397 Reduced 14.36%	2,367 $812,000
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $52,412 - $61,071	163 Added 6.27%	2,764 $1.01 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $96,948 - $110,483	327 Added 14.38%	2,601 $841,000
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $60,763 - $71,344	218 Added 10.6%	2,274 $737,000
Q1 2022 May 11, 2022	BUY	$234.69 - $291.66 $12,438 - $15,457	53 Added 2.65%	2,056 $589,000
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $88,640 - $109,083	400 Added 24.95%	2,003 $463,000
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $49,296 - $63,816	300 Added 23.02%	1,603 $299,000
Q4 2020 Feb 08, 2021	BUY	$130.46 - $172.63 $169,989 - $224,936	1,303 New	1,303 $220,000
Q3 2020 Nov 05, 2020	SELL	$146.22 - $169.13 $188,185 - $217,670	-1,287 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $175,572 - $211,299	1,287 New	1,287 $211,000
Q1 2020 May 11, 2020	SELL	$119.05 - $147.35 $898,589 - $1.11 Million	-7,548 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$106.92 - $132.43 $249,123 - $308,561	2,330 Added 44.65%	7,548 $992,000
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $49,855 - $58,194	-450 Reduced 7.94%	5,218 $578,000
Q1 2019 May 09, 2019	SELL	$111.31 - $131.02 $26,157 - $30,789	-235 Reduced 3.98%	5,668 $735,000
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $42,465 - $47,574	401 Added 7.29%	5,903 $683,000
Q2 2018 Aug 10, 2018	BUY	$75.7 - $86.88 $416,501 - $478,013	5,502 New	5,502 $469,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $693B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roundview Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roundview Capital LLC with notifications on news.

Account

Roundview Capital LLC Eli Lilly & CO Transaction History